investor.meipharma.com investor.meipharma.com

investor.meipharma.com

MEI Pharma - Investors

Aug 4, 2015. MEI Pharma to Present at Wedbush PacGrow Healthcare Conference. Jul 1, 2015. MEI Pharma to Present at Cantor Fitzgerald Healthcare Conference. Jun 12, 2015. MEI Pharma Reports Updated Results from Phase II Study of Pracinostat and Azacitidine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia. May 6, 2015. MEI Pharma to Present at Bank of America Merrill Lynch Health Care Conference. Wedbush PacGrow Healthcare Conference Presentation. Vice President, Investor Relations.

http://investor.meipharma.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR INVESTOR.MEIPHARMA.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

January

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Sunday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.0 out of 5 with 15 reviews
5 star
6
4 star
5
3 star
3
2 star
0
1 star
1

Hey there! Start your review of investor.meipharma.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

0.8 seconds

FAVICON PREVIEW

  • investor.meipharma.com

    16x16

CONTACTS AT INVESTOR.MEIPHARMA.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
MEI Pharma - Investors | investor.meipharma.com Reviews
<META>
DESCRIPTION
Aug 4, 2015. MEI Pharma to Present at Wedbush PacGrow Healthcare Conference. Jul 1, 2015. MEI Pharma to Present at Cantor Fitzgerald Healthcare Conference. Jun 12, 2015. MEI Pharma Reports Updated Results from Phase II Study of Pracinostat and Azacitidine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia. May 6, 2015. MEI Pharma to Present at Bank of America Merrill Lynch Health Care Conference. Wedbush PacGrow Healthcare Conference Presentation. Vice President, Investor Relations.
<META>
KEYWORDS
1 close
2 about us
3 management
4 directors
5 our programs
6 newsroom
7 investors
8 stock information
9 events and webcasts
10 sec filings
CONTENT
Page content here
KEYWORDS ON
PAGE
close,about us,management,directors,our programs,newsroom,investors,stock information,events and webcasts,sec filings,annual report,analyst coverage,corporate governance,news alerts,contact ir,financial reporting,careers,latest press releases,stock quote
SERVER
Apache
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

MEI Pharma - Investors | investor.meipharma.com Reviews

https://investor.meipharma.com

Aug 4, 2015. MEI Pharma to Present at Wedbush PacGrow Healthcare Conference. Jul 1, 2015. MEI Pharma to Present at Cantor Fitzgerald Healthcare Conference. Jun 12, 2015. MEI Pharma Reports Updated Results from Phase II Study of Pracinostat and Azacitidine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia. May 6, 2015. MEI Pharma to Present at Bank of America Merrill Lynch Health Care Conference. Wedbush PacGrow Healthcare Conference Presentation. Vice President, Investor Relations.

INTERNAL PAGES

investor.meipharma.com investor.meipharma.com
1

MEI Pharma - Corporate Governance

http://investor.meipharma.com/corporate-governance

Skip to main content. Corporate Governance involves the processes and procedures used to manage the business affairs of a company and includes the structure and balance of power between the management and board. This section provides charters and codes of conduct developed for the various board committees. Code of Business Conduct and Ethics. Nominating and Governance Committee Charter. 2016 MEI Pharma Inc. Terms and Conditions.

2

MEI Pharma - SEC Filings

http://investor.meipharma.com/sec-filings

Skip to main content. Select the filing type and date range you wish to view from the drop-down menus below. Proxy and Information Statements. Official notification to shareholders of matters to be brought to a vote ("Proxy"). Oct 17, 2016. Additional proxy soliciting materials - definitive. Oct 17, 2016. Annual report which provides a comprehensive overview of the company for the past year. Sep 6, 2016. Report of unscheduled material events or corporate event. Sep 2, 2016. Aug 24, 2016. Aug 22, 2016.

3

MEI Pharma to Present at Bank of America Merrill Lynch Health Care Conference - May 6, 2015

http://investor.meipharma.com/2015-05-06-MEI-Pharma-to-Present-at-Bank-of-America-Merrill-Lynch-Health-Care-Conference

Skip to main content. MEI Pharma to Present at Bank of America Merrill Lynch Health Care Conference. Live Webcast from Las Vegas on May 13th. May 6, 2015. Wednesday, May 6, 2015 (6:00am). May 6, 2015. MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that Daniel P. Gold. PhD, President and Chief Executive Officer, will present at the Bank of America Merrill Lynch 2015 Health Care Conference on Wednesday, May 13, 2015.

4

MEI Pharma - NewsRoom

http://investor.meipharma.com/news

Skip to main content. Get News Alerts by Email. Aug 10, 2016. MEI Pharma to Present at Wedbush PacGrow Healthcare Conference. Live Webcast from New York on August 16th. Aug 8, 2016. Helsinn Group and MEI Pharma Enter Strategic Agreement for the Development and Commercialization of Pracinostat for the Treatment of Acute Myeloid Leukemia and Other Hematologic Diseases. Aug 1, 2016. Median overall survival from Phase II study reached at 19.1 months. Apr 20, 2016. Apr 5, 2016. Feb 1, 2016. Dec 10, 2015.

5

MEI Pharma Reports Updated Results from Phase II Study of Pracinostat and Azacitidine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia - Jun 12, 2015

http://investor.meipharma.com/2015-06-12-MEI-Pharma-Reports-Updated-Results-from-Phase-II-Study-of-Pracinostat-and-Azacitidine-in-Elderly-Patients-with-Newly-Diagnosed-Acute-Myeloid-Leukemia

Skip to main content. MEI Pharma Reports Updated Results from Phase II Study of Pracinostat and Azacitidine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia. Clinical Responses Continue to Improve; Median Overall Survival Not Yet Reached. Jun 12, 2015. Friday, June 12, 2015 (5:00am). June 12, 2015. Logo - http:/ photos.prnewswire.com/prnh/20140805/133834. To date, 27 of 50 patients (54%) have achieved the primary endpoint of complete response (CR) plus complete response with incomplete blo...

UPGRADE TO PREMIUM TO VIEW 9 MORE

TOTAL PAGES IN THIS WEBSITE

14

LINKS TO THIS WEBSITE

storytrading.com storytrading.com

MEIP – StoryTrading

http://www.storytrading.com/meip

Post a Trade Idea. Every Trade Needs a Good Story! Post a Trade Idea. Skip to primary content. Skip to secondary content. August 11, 2015. MEIP 1.76 0.02 1.15%. Original Content from StoryTrading:. Here’s an Update on our top Story Trades Ideas. Updated Positions: CBLI, CAPN, APDN, ADAT, MEIP, ATNM, AIMT, WPCS and more…. MEIP, Trading Below Cash, Could be the Next AQXP: $4 – $14 Target. Last week at the Wedbush PacGrowth Healthcare Conference, the CEO revealed new data points and had very positive remark...

meipharma.com meipharma.com

About Us | MEI Pharma

http://www.meipharma.com/about-us

Skip to main content. Pracinostat has been tested in more than 300 patients to date in multiple Phase I and Phase II clinical trials, including advanced hematologic diseases such as AML, myelodysplastic syndrome and myelofibrosis. In December 2015, we announced positive results from a Phase II study of Pracinostat in elderly patients with newly diagnosed AML and plans to initiate a Phase III registration study in the second half of 2016. MEI Pharma is listed on the Nasdaq Capital Market (Nasdaq: MEIP).

meipharma.com meipharma.com

Our Programs | MEI Pharma

http://www.meipharma.com/our-programs

Skip to main content. Front Line, Elderly, Unfit. Front Line and Relapsed/Refractory. ME-401 PI3K Delta Inhibitor. Recurrent CLL or follicular NHL. Single Agent, Dose Escalation. 2016 MEI Pharma Inc. Terms and Conditions.

meipharma.com meipharma.com

Careers | MEI Pharma

http://www.meipharma.com/careers

Skip to main content. MEI Pharma's staff is a team of friendly, dedicated, experienced and collaborative professionals committed to the hard work that supports our company's aggressive goals and to the workplace values that promote our success. Our workplace values include:. Shared commitement to excellence and collaboration across functions. Personal accountability for consistent superior performance. Fiscal discipline applied wisely in the use of resources. Records and Technical Information Specialist.

meipharma.com meipharma.com

ME-344 | MEI Pharma

http://www.meipharma.com/our-programs/me-344

Skip to main content. Our isoflavone-based mitochondrial inhibitor drug candidate, ME-344, displays a novel mechanism of action, targeting a mitochondrial component of the terminal respiratory chain complex in rapidly proliferating cells. Treatment of tumor cells with these compounds has been shown to induce cancer cell death through the induction of DNA fragmentation and through a process known as destructive autophagy, wherein a cell consumes itself. And delay recurrence in a pre-clinical. In patients ...

meipharma.com meipharma.com

Our Programs | MEI Pharma

http://www.meipharma.com/our-programs/hdac-inhibitor

Skip to main content. Front Line, Elderly, Unfit. Front Line and Relapsed/Refractory. ME-401 PI3K Delta Inhibitor. Recurrent CLL or follicular NHL. Single Agent, Dose Escalation. 2016 MEI Pharma Inc. Terms and Conditions.

UPGRADE TO PREMIUM TO VIEW 11 MORE

TOTAL LINKS TO THIS WEBSITE

17

OTHER SITES

investor.mdsol.com investor.mdsol.com

Investor Relations | Medidata Solutions, Inc.

Skip to main navigation. Stock Quote and Chart. Annual Reports and Proxies. Life Science Leaders Gather at Medidata NEXT Basel and Frankfurt to Examine New Opportunities to Improve Clinical Development and Better Patient Lives. How Do Technology and Data Accelerate Precision Medicine in Oncology? Industry Experts to Discuss During Medidata Webinar. 1 917 522 4620. How may we help you?

investor.mdu.com investor.mdu.com

Investor Relations | MDU Resources Group, Inc.

Skip to main navigation. MDU Resources Group, Inc., a member of the S&P MidCap 400 index and the S&P High-Yield Dividend Aristocrats index, provides essential products and services through its regulated energy delivery and construction materials and services businesses. Asset-based natural resource company. Solid balance sheet with equity of 59% of total capital at Dec. 31. 80 consecutive years of uninterrupted quarterly common stock dividend payments. Member of S&P MidCap 400 Index. Mar 29, 2018.

investor.me investor.me

Investor.me - Email and Direct Mail Lists for Investor Relations (IR) Marketers

Welcome to Investor.me! Are you are an Email or Direct Mail Marketer of Investment Services, Investment Newsletters, Money Management Services, Investment Seminars, or Investor Relations (IR) type offers? If so, we have targeted lists. That will get your specific message into the hands of individual investors who are looking for information and advice to build their personal wealth with stocks. Are you ready to get started? If so, send an email by. Oil, Gas and Energy. That reach active investors:.

investor.medimmune.com investor.medimmune.com

MedImmune | Investors | Investor Relations Home

MedImmune is part of the AstraZeneca group of companies. Please direct all investor relations inquiries to AstraZeneca. To access investor relations information on AstraZeneca's website. Maryland Regional Biotech Forum Aims to Propel Washington, D.C. Metro Region to a Top Three Ranked U.S. Biotech Hub by 2023. MedImmune Presents Promising New Data in Systemic Lupus at American College of Rheumatology Meeting.

investor.medpace.com investor.medpace.com

Overview | Investors | Medpace

Infectious Disease and Vaccines. Rare and Orphan Disease. Clinical Trial Management System. Interactive Voice/Web Response System. Laboratory Information Management System. Data Management / Electronic Data Capt. Medpace Holdings, Inc. Cincinnati, OH 45227. Date as of  01/12/17 10:12 am ET. Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources. November 3, 2016. Medpace Holdings, Inc. Reports Third Quarter 2016 Results. October 24, 2016. October 17, 2016.

investor.meipharma.com investor.meipharma.com

MEI Pharma - Investors

Aug 4, 2015. MEI Pharma to Present at Wedbush PacGrow Healthcare Conference. Jul 1, 2015. MEI Pharma to Present at Cantor Fitzgerald Healthcare Conference. Jun 12, 2015. MEI Pharma Reports Updated Results from Phase II Study of Pracinostat and Azacitidine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia. May 6, 2015. MEI Pharma to Present at Bank of America Merrill Lynch Health Care Conference. Wedbush PacGrow Healthcare Conference Presentation. Vice President, Investor Relations.

investor.memorialpp.com investor.memorialpp.com

Investor Relations - Memorial Production Partners LP

Environmental Health & Safety. Memorial Production Partners LP is an upstream Master Limited Partnership (MLP) focused on the acquisition, production and development of oil and gas properties in the United States. Our properties consist of mature, legacy oil and natural gas fields. Our primary business objective is to generate stable cash flows, allowing us to make quarterly cash distributions to our unitholders and, over time, to increase those quarterly cash distributions. Unit data, history.

investor.mencast.com.sg investor.mencast.com.sg

Mencast Holdings - Investor Relations: Mencast Holdings IR

This website is best viewed in 1200x768 pixels screen resolution and above. Comprehensive MRO Solutions Provider in the Offshore, Marine and Oil and Gas Industries. At present, our Group services our customers through its three business segments, being Offshore and Engineering, Marine, and Energy Services. Welcome to the Mencast Newsroom. Here you'll find our latest news releases, press releases, events and our financial news. Welcome to Mencast Holdings Investor Relations. We keep economies moving.

investor.mercadolibre.com investor.mercadolibre.com

Investor Relations | Mercadolibre, Inc.

Skip to main navigation. Mercado Libre - Donde comprás y vendés de todo. Annual Reports and SEC. Annual Reports and SEC. Feb 22, 2018. MercadoLibre, Inc. Reports Fourth Quarter and Full Year 2017 Financial Results. Feb 15, 2018. MercadoLibre, Inc. to Report Fourth Quarter 2017 Financial Results. Nov 2, 2017. MercadoLibre, Inc. Reports Third Quarter Financial Results. 742 million Sold Items, up 55.8%, 62.3 million Total Payment Transactions, up 69.4% Net Revenues of $370.7 million , growin...

investor.mercuryinsurance.com investor.mercuryinsurance.com

Mercury Insurance | Save money on your auto insurance and more with Mercury

How to File a Claim. Login to Your Account. Make a One-Time Payment. Low Rates and Incredible Service. Get a Fast, Free Quote. Or call us at (800) 882-9121. Retrieve a Saved Quote. Prefer to talk to a real, live person? Give us a call at (800) 956-3728. Low Rates and Incredible Service. Get an auto insurance quote and buy your policy online. MAKE A ONE-TIME PAYMENT. Find an Agent Near You. Let a Mercury agent do the work for you. Just enter your zip code or browse agents by state. News You Can Use. A com...

investor.meridianbanker.com investor.meridianbanker.com

Meridian Bank - Investor Information

Corporate Headquarters in Malvern. View our quarterly and. Click here to visit. Meridian's Main Web Site. Meridian Bank â Innovative. Like You. Equal Housing Lender â Member FDIC.